Table 1 Patient characteristics at admission and transplantation modalities by group

Age: months, mean (range)

131.2 (4.1–251.4)

132.4 (10.3–213.1)

NS

Sex: M/F, n,

4/10

16/12

NS

Diagnosis of Malignant Disease, n,(%)

12 (85.7)

23 (82.1)

NS

CR at transplant for malignant disease,n, (%)

8 (61.5)

17 (70.8)

NS

Donor, n, (%):

NS

 • Sibling HLA identical

1 (7.2)

5 (17.9)

 • MUD

7 (50)

19 (67.8)

 • MMUD

3 (21.4)

1 (3.6)

 • Haploidentical

3 (21.4)

3 (10.7)

Stem cell source, n, (%):

NS

 • BM

12 (85.8)

26 (92.9)

 • PBSC

1 (7.1)

2 (7.1)

 • CB

1 (7.1)

0 (0)

Sex Mismatch, n, (%)

7 (50)

15 (53.6)

NS

Infused stem cell dose, median (x10⁸ MNC/kg)

4.71

4.66

NS

Conditioning regimens, n, (%):

 • MAC

13 (92.9)

23 (82.1)

NS

 • With ATG

10 (71.4)

20 (71.4)

NS

BMI, mean

17.56

18.76

NS

BMI Z-score, mean

−0.37

−0.06

NS